Verapamil Calan A Calcium Channel Blocker for Heart Rhythm and Blood Pressure

Welcome to this in-depth guide designed to provide comprehensive information about Calan, a medication widely prescribed in the United States and globally. Understanding your medication is a crucial step towards effective management of your health, and we are committed to providing clear, reliable details to help you make informed decisions in consultation with your healthcare provider. This resource aims to cover all essential aspects of Calan, from its mechanism of action to its approved uses, potential side effects, and important safety considerations.

Calan, with its active ingredient Verapamil, is a well-established pharmaceutical agent belonging to the class of medications known as calcium channel blockers. It plays a vital role in managing several significant cardiovascular conditions, helping millions of individuals maintain better heart health and an improved quality of life. This guide will delve into how Calan works within the body, for which conditions it is typically prescribed, and what you should know to use it safely and effectively.

What is Calan (Verapamil)?

Calan is the brand name for the active pharmaceutical ingredient Verapamil hydrochloride. Verapamil is classified as a calcium channel blocker, specifically a phenylalkylamine-type calcium channel blocker. Its primary action involves blocking the influx of extracellular calcium ions across the membranes of myocardial (heart muscle) and vascular smooth muscle cells. This blockade of calcium channels leads to several beneficial physiological effects relevant to cardiovascular health.

When calcium channels are blocked, several key actions occur:

• Vasodilation: Verapamil causes the smooth muscles in the walls of blood vessels to relax, leading to the widening (dilation) of arteries, particularly peripheral arteries. This reduces the resistance against which the heart has to pump blood, thereby lowering blood pressure.
• Reduced Myocardial Contractility: By limiting calcium entry into heart muscle cells, Verapamil decreases the force with which the heart muscle contracts. While this might sound concerning, for conditions like angina, it reduces the heart’s workload and oxygen demand.
• Decreased Heart Rate: Verapamil slows the conduction of electrical impulses through the atrioventricular (AV) node, a critical part of the heart’s electrical system. This action reduces the heart rate and is particularly useful in managing certain types of rapid heart rhythms.
• Improved Myocardial Oxygen Supply: The dilation of coronary arteries (blood vessels supplying the heart muscle itself) can increase blood flow and oxygen supply to the heart, which is beneficial in conditions involving inadequate oxygen to the heart muscle.

These combined effects make Calan a versatile medication for managing a range of cardiovascular disorders, primarily focused on blood pressure regulation, relief from chest pain, and control of irregular heart rhythms. It is available in various formulations, including immediate-release tablets (Calan) and extended-release tablets (often branded as Calan SR), allowing for flexible dosing regimens tailored to individual patient needs and the specific condition being treated.

Approved Indications for Calan (Verapamil)

Calan is officially approved and widely used for the treatment of several significant cardiovascular conditions. Its efficacy in these areas has been well-established through extensive clinical research and practical application across the United States and other regions. It is crucial to use Calan only for its approved indications, as prescribed by a healthcare professional.

Management of Hypertension (High Blood Pressure)

One of the primary uses of Calan is in the treatment of Hypertension, commonly known as high blood pressure. Hypertension is a widespread condition in the US that significantly increases the risk of heart attack, stroke, kidney disease, and other serious health problems if left uncontrolled. Verapamil helps to lower blood pressure primarily by relaxing the smooth muscles in the walls of arteries, leading to vasodilation. This reduction in peripheral vascular resistance decreases the workload on the heart and allows blood to flow more easily, thereby reducing blood pressure. By effectively managing Hypertension, Calan contributes to reducing the risk of these adverse cardiovascular events and improving long-term health outcomes.

Treatment of Angina Pectoris (Chest Pain)

Calan is also indicated for the management of Angina Pectoris, which is chest pain or discomfort caused by reduced blood flow to the heart muscle. Angina typically occurs when the heart muscle isn’t getting enough oxygen-rich blood, often during physical exertion or emotional stress. Verapamil addresses angina through several mechanisms:

• Reducing Myocardial Oxygen Demand: By decreasing heart rate and myocardial contractility, Calan reduces the amount of oxygen the heart muscle needs to function.
• Increasing Myocardial Oxygen Supply: Verapamil can dilate coronary arteries, which are the blood vessels that supply oxygen to the heart muscle itself. This can increase blood flow and oxygen delivery to areas of the heart that are experiencing ischemia (lack of oxygen).

These actions help to prevent or relieve anginal episodes, allowing individuals to experience less chest pain and improve their exercise tolerance and overall quality of life. Calan is effective for both chronic stable angina and vasospastic (Prinzmetal’s) angina.

Control of Cardiac Arrhythmias (Irregular Heartbeat)

Another critical application of Calan is in the management of certain Cardiac Arrhythmias, which are irregular heartbeats. Verapamil is particularly effective for supraventricular tachyarrhythmias, which originate in the upper chambers of the heart. Its action on the AV node is key here:

• Slowing AV Nodal Conduction: Verapamil significantly slows the conduction of electrical impulses through the atrioventricular (AV) node. This property is invaluable in controlling the ventricular rate in conditions such as atrial fibrillation and atrial flutter, where the atria beat very rapidly and irregularly. By slowing conduction through the AV node, Calan prevents these rapid atrial impulses from being fully transmitted to the ventricles, thus preventing excessively fast and potentially dangerous ventricular heart rates.
• Terminating Paroxysmal Supraventricular Tachycardia (PSVT): In some cases, intravenous Verapamil is used to rapidly convert episodes of PSVT, a type of abnormally fast heart rhythm, back to a normal rhythm.

By regulating heart rhythm, Calan helps to prevent symptoms such as palpitations, dizziness, and shortness of breath associated with these arrhythmias, improving patient comfort and reducing the risk of complications.

Dosage and Administration of Calan

The dosage and administration of Calan (Verapamil) must be individualized by a healthcare professional based on the specific condition being treated, the patient’s response to therapy, and their overall health status. It is crucial to follow your doctor’s instructions precisely and never adjust your dose without medical advice.

General Dosing Guidelines:

• Immediate-Release Tablets (Calan): These tablets are typically taken two to three times daily. For Hypertension, initial doses might range from 80 mg to 120 mg three times a day, with adjustments made as needed. For Angina, similar dosing schedules apply. For Arrhythmias, dosing is highly individualized, often starting lower and increasing as tolerated.
• Extended-Release Tablets (Calan SR): These formulations are designed for once-daily dosing, which can enhance patient convenience and compliance. Doses often range from 120 mg to 480 mg once daily. The extended-release forms provide a more consistent level of medication in the bloodstream throughout the day.

Important Administration Considerations:

• Consistency: Take Calan at approximately the same time each day to maintain stable drug levels.
• With or Without Food: Calan can usually be taken with or without food. However, taking it consistently in the same manner (e.g., always with food) is often recommended.
• Swallowing Tablets: Extended-release tablets should be swallowed whole and not crushed, chewed, or divided, as this can alter the drug’s release mechanism and lead to an overdose or reduced effectiveness.
• Missed Dose: If you miss a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and resume your regular dosing schedule. Do not take a double dose to make up for a missed one.

Close monitoring of blood pressure, heart rate, and electrocardiogram (ECG) may be necessary, especially during the initiation of therapy and dose adjustments, to ensure optimal therapeutic effect and minimize potential side effects.

Important Safety Information: Side Effects of Calan

Like all medications, Calan (Verapamil) can cause side effects, although not everyone experiences them. It is important to be aware of potential side effects and to discuss any concerns with your healthcare provider. Many side effects are mild and transient, but some can be more serious.

Common Side Effects (may affect up to 1 in 10 people):

• Constipation: This is one of the most frequently reported side effects, especially with higher doses. It occurs due to Verapamil’s effect on smooth muscle, including those in the gastrointestinal tract.
• Headache: Often mild and can improve with continued use.
• Dizziness/Lightheadedness: Can occur, particularly when standing up quickly, due to the blood pressure-lowering effects.
• Nausea: Generally mild and can be managed by taking the medication with food.
• Fatigue/Tiredness: A general feeling of reduced energy.
• Peripheral Edema: Swelling in the ankles, feet, or legs, due to vasodilation. This is usually mild.
• Flushing: A sensation of warmth and redness of the skin.
• Bradycardia: A slower than normal heart rate.

Less Common but Potentially Serious Side Effects (seek medical attention if experienced):

• Severe Hypotension: A significant drop in blood pressure that causes severe dizziness, fainting, or weakness.
• Heart Failure Exacerbation: In patients with pre-existing heart failure, Verapamil can worsen symptoms due to its negative inotropic effect (decreases heart contractility).
• Significant Bradycardia or AV Block: Heart rates that are dangerously slow or severe blockages in the heart’s electrical conduction system can occur, potentially requiring immediate medical intervention.
• Liver Enzyme Elevation: Rarely, Verapamil can cause an increase in liver enzymes, indicating potential liver stress. Symptoms might include yellowing of the skin or eyes (jaundice), dark urine, or persistent nausea and vomiting.
• Allergic Reactions: Signs include rash, itching, swelling (especially of the face, tongue, or throat), severe dizziness, or trouble breathing.

Always inform your doctor about any side effects you experience, especially if they are persistent, bothersome, or severe. Your doctor may adjust your dose or consider an alternative medication.

Precautions and Warnings for Calan Use

Before starting Calan (Verapamil) and throughout your treatment, it is important to be aware of certain precautions and warnings to ensure safe and effective use. Your healthcare provider will consider your complete medical history before prescribing this medication.

Contraindications (Conditions where Calan should NOT be used):

• Severe Left Ventricular Dysfunction: Verapamil can worsen heart failure in individuals with severely weakened heart pumping function due to its negative inotropic effects.
• Hypotension (Low Blood Pressure): Patients with systolic blood pressure less than 90 mmHg should generally avoid Calan, as it can further lower blood pressure.
• Cardiogenic Shock: A severe form of heart failure where the heart cannot pump enough blood to meet the body’s needs.
• Sick Sinus Syndrome (unless a pacemaker is in place): A disorder of the heart’s natural pacemaker that can lead to dangerously slow heart rates.
• Second- or Third-Degree AV Block (unless a pacemaker is in place): Severe blockages in the electrical conduction system of the heart.
• Atrial Flutter or Atrial Fibrillation with an Accessory Bypass Tract: Such conditions can lead to dangerously rapid heart rates if Verapamil is used.

Use With Caution (Requires close monitoring):

• Elderly Patients: Older adults may be more sensitive to the blood pressure-lowering and heart rate-slowing effects of Verapamil, requiring lower starting doses and careful titration.
• Patients with Impaired Liver Function: Verapamil is extensively metabolized by the liver. Liver impairment can lead to higher and prolonged drug levels, increasing the risk of side effects. Dosage adjustments are often necessary.
• Patients with Impaired Renal (Kidney) Function: While less critical than liver function, kidney impairment can also affect Verapamil excretion. Monitoring is advised.
• Patients on Beta-Blockers: Concomitant use with beta-blockers requires extreme caution due to the additive effects on heart rate and AV nodal conduction, potentially leading to severe bradycardia or heart block.
• Patients with Neuromuscular Disease: Verapamil can exacerbate conditions like Duchenne’s muscular dystrophy and myasthenia gravis due to its calcium channel blocking effects on neuromuscular transmission.
• History of Heart Failure: Even in less severe cases, Verapamil should be used with caution and close monitoring.

Always provide your healthcare provider with a complete list of all your medical conditions, medications (prescription, over-the-counter, and herbal supplements), and allergies before starting Calan. Regular follow-up appointments are essential to monitor your response to the medication and assess for any potential adverse effects.

Drug Interactions with Calan (Verapamil)

Calan (Verapamil) can interact with a wide range of other medications, dietary supplements, and even certain foods. These interactions can alter the effectiveness of Calan or the other drugs, or increase the risk of adverse effects. It is vital to inform your healthcare provider about all medications you are currently taking, including prescription drugs, over-the-counter medications, herbal remedies, and dietary supplements.

Significant Drug Interactions:

• Beta-Blockers (e.g., Propranolol, Metoprolol): Co-administration can lead to additive effects on heart rate and AV nodal conduction, potentially causing severe bradycardia, heart block, or exacerbation of heart failure. This combination should be used with extreme caution and close monitoring, if at all.
• Digoxin: Verapamil can increase digoxin levels in the blood, leading to an increased risk of digoxin toxicity. Dosage adjustment of digoxin may be necessary, and digoxin levels should be monitored closely.
• Statins (e.g., Simvastatin, Lovastatin, Atorvastatin): Verapamil is an inhibitor of CYP3A4, an enzyme responsible for metabolizing several statins. This can significantly increase statin levels, raising the risk of muscle-related side effects like myopathy or rhabdomyolysis. Lower doses of statins or alternative statins may be required.
• Grapefruit Juice: Grapefruit juice inhibits CYP3A4 in the gut, which can increase the bioavailability and plasma concentration of Verapamil, potentially leading to increased blood pressure-lowering effects and other side effects. It is generally advised to avoid grapefruit juice while taking Calan.
• Antiarrhythmics (e.g., Amiodarone, Flecainide): Additive effects on cardiac conduction and contractility can occur, increasing the risk of bradycardia, hypotension, or heart block.
• Antihypertensive Agents (other classes): Concurrent use with other drugs that lower blood pressure (e.g., ACE inhibitors, ARBs, diuretics) can lead to an additive hypotensive effect, potentially causing excessive drops in blood pressure.
• Cyclosporine, Tacrolimus, Sirolimus, Everolimus: Verapamil can increase the blood levels of these immunosuppressants, necessitating a reduction in their dosage and close monitoring of drug levels.
• Theophylline: Verapamil can increase theophylline levels, potentially leading to toxicity.
• Carbamazepine, Phenytoin, Phenobarbital: These anticonvulsants are CYP3A4 inducers and can decrease Verapamil plasma levels, reducing its effectiveness. Conversely, Verapamil can increase carbamazepine levels, potentially leading to toxicity.
• Lithium: Verapamil can increase lithium neurotoxicity.

This is not an exhaustive list. Always consult your doctor or pharmacist for a complete list of potential drug interactions and personalized advice. Do not start or stop any medication without discussing it with your healthcare provider.

Overdose Information for Calan (Verapamil)

An overdose of Calan (Verapamil) can be a serious medical emergency and requires immediate attention. If you suspect an overdose, seek emergency medical help right away or contact a poison control center.

Symptoms of Overdose:

The symptoms of a Verapamil overdose are primarily extensions of its pharmacological effects and can include:

• Severe Hypotension: A dangerously low blood pressure can lead to dizziness, lightheadedness, weakness, and fainting.
• Profound Bradycardia: An extremely slow heart rate, potentially leading to insufficient blood flow to the brain and other organs.
• Second- or Third-Degree AV Block: Severe disturbances in the heart’s electrical conduction, which can be life-threatening.
• Asystole: Complete cessation of electrical activity in the heart (cardiac arrest) in severe cases.
• Cardiogenic Shock: The heart’s inability to pump enough blood to meet the body’s needs.
• Metabolic Acidosis: An imbalance in the body’s acid-base status.
• Hyperglycemia: Elevated blood sugar levels.

In some cases, central nervous system depression, seizures, and respiratory distress may also occur. The severity of symptoms can depend on the amount of medication taken and the individual’s overall health.

Actions to Take:

• Seek Immediate Medical Attention: Call emergency services (e.g., 911 in the US) or go to the nearest emergency room immediately.
• Provide Information: Be prepared to tell medical professionals what medication was taken, the approximate amount, and when it was taken.
• Do Not Induce Vomiting: Unless specifically instructed by a medical professional, do not attempt to induce vomiting.

Treatment for Verapamil overdose typically involves supportive care and measures to counteract its cardiovascular effects, such as intravenous fluids, calcium gluconate, atropine for bradycardia, vasopressors for hypotension, and in some severe cases, cardiac pacing. Early recognition and intervention are critical for a positive outcome.

Storage of Calan (Verapamil)

Proper storage of Calan (Verapamil) is essential to maintain its efficacy and safety. Always follow the storage instructions provided on the medication label and by your pharmacist.

• Room Temperature: Store Calan tablets at controlled room temperature, typically between 68°F and 77°F (20°C and 25°C). Avoid extreme temperatures.
• Protect from Moisture: Keep the medication in its original container, tightly closed, to protect it from moisture. Do not store it in the bathroom or other areas where it might be exposed to humidity.
• Protect from Light: Keep Calan away from direct light.
• Keep Out of Reach of Children and Pets: Medications should always be stored securely out of the sight and reach of children and pets to prevent accidental ingestion.
• Do Not Use Expired Medication: Check the expiration date on the package. Do not use Calan if it has passed its expiration date, as it may no longer be effective or safe. Dispose of expired or unused medication properly according to local regulations; do not flush down the toilet or throw in regular trash unless instructed to do so.

Benefits of Calan (Verapamil)

Calan (Verapamil) offers significant therapeutic benefits for individuals managing cardiovascular conditions. Its multifaceted mechanism of action provides comprehensive advantages:

• Effective Blood Pressure Control: For patients with Hypertension, Calan effectively lowers blood pressure, reducing the strain on the cardiovascular system and mitigating the risk of serious complications such as stroke, heart attack, and kidney damage. This control is vital for long-term cardiovascular health in the US.
• Angina Relief and Prevention: Calan significantly reduces the frequency and severity of Angina Pectoris episodes. By decreasing the heart’s oxygen demand and improving coronary blood flow, it helps alleviate chest pain, enhances exercise tolerance, and improves the overall quality of life for individuals suffering from angina.
• Heart Rhythm Regulation: In cases of certain Cardiac Arrhythmias, particularly supraventricular tachyarrhythmias like atrial fibrillation and atrial flutter, Calan is highly effective at controlling the ventricular rate. This helps to normalize heart rhythm, reduce symptoms like palpitations and dizziness, and prevent potentially dangerous rapid heart rates.
• Improved Cardiovascular Outcomes: By effectively managing these conditions, Calan contributes to a lower incidence of cardiovascular morbidity and mortality, helping patients lead healthier and more active lives.
• Versatility: Available in both immediate-release and extended-release formulations, Calan offers flexibility in dosing regimens, allowing healthcare providers to tailor treatment to individual patient needs and improve adherence, especially with convenient once-daily extended-release options.

The consistent and appropriate use of Calan, under the guidance of a healthcare professional, can lead to substantial improvements in cardiovascular health and patient well-being.

Lifestyle and Calan

While Calan (Verapamil) is a powerful medication for managing cardiovascular conditions, its effectiveness can be significantly enhanced by adopting a healthy lifestyle. Integrating positive lifestyle choices into your routine can complement your medication therapy and contribute to overall better health outcomes.

• Balanced Diet: Adopting a heart-healthy diet, such as the DASH (Dietary Approaches to Stop Hypertension) diet, which emphasizes fruits, vegetables, whole grains, lean proteins, and low-fat dairy, can help manage blood pressure and cholesterol levels. Limiting sodium intake is particularly important for individuals with Hypertension.
• Regular Physical Activity: Engaging in regular, moderate-intensity exercise, as approved by your doctor, can improve cardiovascular health, help maintain a healthy weight, and reduce stress. Aim for at least 150 minutes of moderate-intensity aerobic activity or 75 minutes of vigorous-intensity activity per week.
• Weight Management: Achieving and maintaining a healthy body weight can significantly reduce the burden on your heart and improve the effectiveness of blood pressure and angina medications.
• Stress Reduction: Chronic stress can contribute to high blood pressure and other cardiovascular issues. Incorporating stress-reducing techniques such as meditation, yoga, deep breathing exercises, or hobbies can be beneficial.
• Limiting Alcohol Intake: Excessive alcohol consumption can raise blood pressure and interfere with medication effectiveness. If you drink alcohol, do so in moderation.
• Smoking Cessation: If you smoke, quitting is one of the most impactful steps you can take for your cardiovascular health. Smoking severely damages blood vessels and increases the risk of heart disease.

Discuss these lifestyle changes with your healthcare provider to create a personalized plan that supports your medication regimen and optimizes your health.

Table of Calan (Verapamil) Characteristics

Characteristic	Description
Active Ingredient	Verapamil Hydrochloride
Drug Class	Calcium Channel Blocker (Phenylalkylamine type)
Primary Approved Uses	Hypertension (High Blood Pressure) Angina Pectoris (Chest Pain) Certain Cardiac Arrhythmias (e.g., supraventricular tachyarrhythmias, atrial fibrillation, atrial flutter)
Mechanism of Action	Blocks influx of calcium ions into cardiac and vascular smooth muscle, leading to vasodilation, decreased heart rate, and reduced myocardial contractility.
Formulations Available	Immediate-release tablets (Calan), Extended-release tablets (Calan SR)
Common Side Effects	Constipation, headache, dizziness, nausea, fatigue, peripheral edema, bradycardia.
Important Contraindications	Severe left ventricular dysfunction, hypotension, sick sinus syndrome (without pacemaker), 2nd/3rd-degree AV block (without pacemaker), atrial fibrillation/flutter with accessory bypass tract.
Key Drug Interactions	Beta-blockers, Digoxin, Statins (e.g., Simvastatin), Grapefruit juice, other antihypertensives, immunosuppressants.
Monitoring Parameters	Blood pressure, heart rate, ECG, liver function tests.

Frequently Asked Questions About Calan (Verapamil)

Here are some popular questions about Calan (Verapamil) to help you better understand your medication.

1. How long does it take for Calan to start working?

For immediate-release formulations, Calan can begin to lower blood pressure and heart rate within a few hours of taking the first dose. However, the full therapeutic effects, particularly for conditions like Hypertension and Angina, may take several days to weeks to become evident as your body adjusts to the medication and your doctor fine-tunes the dosage. Extended-release formulations provide a more gradual onset and sustained effect over 24 hours. Consistent daily use is key to achieving and maintaining optimal control of your condition.

2. Can I stop taking Calan suddenly?

No, you should not stop taking Calan suddenly without consulting your healthcare provider. Abrupt discontinuation of Verapamil, especially if you have Angina, can lead to a rebound effect, potentially worsening your angina symptoms or causing other cardiovascular problems. Your doctor will provide specific instructions on how to gradually reduce your dose if discontinuation is necessary, to minimize any risks. Always follow your doctor’s advice regarding medication changes.

3. What should I do if I miss a dose of Calan?

If you miss a dose of Calan, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take a double dose to compensate for a missed one, as this could increase the risk of side effects. If you are unsure, contact your pharmacist or doctor for guidance.

4. Can Calan affect my ability to drive or operate machinery?

Calan can cause dizziness, lightheadedness, or fatigue, especially when you first start taking it or after a dose increase. These effects can impair your ability to drive or operate machinery safely. It is advisable to understand how Calan affects you before engaging in activities that require alertness. If you experience significant dizziness or lightheadedness, avoid driving and consult your doctor.

5. Is Calan safe during pregnancy or while breastfeeding?

The use of Calan during pregnancy is generally not recommended unless clearly necessary and the potential benefits outweigh the risks to the fetus. It is classified as Pregnancy Category C. Verapamil does pass into breast milk and may affect a nursing infant. Therefore, discuss with your healthcare provider whether you should discontinue breastfeeding or choose an alternative medication if you are pregnant, planning to become pregnant, or breastfeeding.

6. What food or drinks should I avoid while taking Calan?

The most significant food interaction with Calan is with grapefruit juice. Grapefruit juice can increase the amount of Verapamil absorbed into your bloodstream, potentially leading to lower blood pressure and other side effects. It is generally recommended to avoid consuming grapefruit and grapefruit juice while taking Calan. Alcohol can also have an additive blood pressure-lowering effect and should be consumed in moderation, if at all, while on this medication.

7. What is the difference between Calan and Calan SR?

Both Calan and Calan SR contain the active ingredient Verapamil. The primary difference lies in their formulation and release mechanism. Calan is an immediate-release tablet, meaning the medication is released into your system relatively quickly, typically requiring multiple doses per day (e.g., two to three times daily). Calan SR (Sustained Release) is an extended-release formulation designed to release the medication slowly over a longer period, allowing for once-daily dosing. This can improve convenience and patient adherence, and maintain more stable drug levels throughout the day.

8. How often do I need to see my doctor while on Calan?

The frequency of doctor visits while on Calan depends on your individual health condition, the stability of your blood pressure and heart rhythm, and any other co-existing medical issues. Initially, your doctor may want to see you more frequently to monitor your response to the medication, adjust the dosage, and check for side effects. Once your condition is stable, routine follow-up visits, typically every 3-6 months, are usually sufficient to ensure the medication remains effective and safe. Always adhere to your doctor’s recommended follow-up schedule.

9. Can Calan cause weight gain?

Weight gain is not commonly listed as a direct side effect of Calan in clinical trials. However, some individuals may experience fluid retention (peripheral edema) as a side effect, which can sometimes be perceived as weight gain. If you are concerned about weight changes while taking Calan, discuss this with your healthcare provider, as other factors or medications could be contributing to it.

10. What exactly is a calcium channel blocker?

A calcium channel blocker, like Verapamil, is a class of medication that works by blocking the entry of calcium ions into the cells of the heart and blood vessel walls. Calcium plays a crucial role in the contraction of heart muscle and the constriction of blood vessels. By blocking these calcium channels, these drugs cause the blood vessels to relax and widen (vasodilation), which lowers blood pressure. They also slow down the heart rate and reduce the heart’s workload, which is beneficial for conditions like Angina and certain Arrhythmias.

This comprehensive guide provides a detailed overview of Calan (Verapamil), an important medication for managing various cardiovascular conditions. Remember that this information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare provider for diagnosis, treatment, and any questions regarding your health or medication. Your doctor is the best resource for personalized advice based on your specific medical history and needs.